Activation of CSPANs in the urinary bladder is likely to be due to the conversion of CYP into its active metabolite, acrolein, and not to a direct effect of CYP upon these nerve-endings.
Introduction
Cyclophosphamide (CYP) is an effective form of treatment for a variety of malignant and non-malignant disease states. Its activity is based upon conversion of CYP into its active oxidized metabolite of phosphamide mustard in the liver. CYP therapy has several toxicity complications (for review see Fraiser et al., 1991) including bladder cystitis, which is due primarily to another CYP metabolite, acrolein. Acrolein has profound effects upon the urinary bladder causing painful voiding symptoms in the mildest of cases to haemorrhagic cystitis in the most severe. It has been shown that CYPinduced cystitis is due to the direct contact of acrolein with the urothelium (Phillips et al., 1961; Cox, 1979) ; however, the exact mechanism of the ensuing inflammatory response is little understood.
Normal vesicourethral function is controlled by a complex interplay between the innervation provided by sympathetic, parasympathetic, somatic and sensory nerves. The latter includes a subpopulation of primary afferent neurones that are sensitive to the actions of capsaicin (Maggi et al., 1986) , the pungent ingredient from red peppers (for review of actions see Holzer, 1991) . These capsaicin-sensitive primary afferent neurones (CSPANs) have been attributed a dual, sensory and efferent function (Maggi, 1990 ). The efferent Author for correspondence. activity of these neurones is achieved by the release of several neuropeptides (Maggi et al., 1987; 1988a,b) many of which possess inflammatory activity, producing what is termed neurogenic inflammation (for reviews see Chahl, 1988; Maggi, 1991) . In turn, various mediators of inflammation, such as bradykinin (Maggi et al., 1989; 1993) and formylmethionyl-leucyl phenylalanine have been shown to induce release of neuropeptides from sensory nerve endings in the urinary bladder. Further evidence for the inflammatory activity of sensory neuropeptides has been demonstrated by the fact that the acute administration of capsaicin itself will result in a plasma protein extravasation (PPE) (Maggi et al., 1987) and that a variety of stimuli for sensory nerves in the bladder, such as xylene and hypertonic solutions, produce inflammatory effects that are dependent upon the existence of an intact sensory afferent system, the response being modified by capsaicin treatment (Maggi et al., 1988b ).
The possible pathophysiological role that activation of CSPANs has to play in CYP-induced cystitis has been investigated previously (Maggi et al., 1992 ) in a rat model of CYP-induced cystitis described by Grinberg-Funes et al. (1990) . This study demonstrated that, at 48 h after administration of CYP, extrinsic bladder denervation produced by bilateral removal of pelvic ganglia resulted in an attenuation of the plasma protein extravasation induced by CYP com-pared to animals with intact bladder innervation. However, prior depletion of sensory neurones with capsaicin potentiated the plasma protein extravasation 48 h after CYP administration. Maggi et al. (1992) suggested that CSPANs may provide some protective effect at this time point, but speculated that at an earlier time-point in the development of the inflammation these nerves may subserve a pro-inflammatory role. To investigate this possibility we have used the same model to determine the development of extravasation induced by CYP from between 0.5 and 48 h after its administration and the effect of capsaicin desensitization upon the development of this response. In this way any role that the sensory afferent system may have to play in CYP-induced plasma extravasation in the rat urinary bladder may be discerned. Secondly, we have addressed the question that CYP produces its effects via conversion to the metabolite, acrolein, by comparison of the effects of both CYP and acrolein upon smooth muscle activity of the rat bladder in vitro and the effects of capsaicin thereon.
Methods

In vivo
Plasma protein extravasation induced by CYP in the urinary bladder of male Wistar rats (Charles River, Italy) weighing 350-400 g, was measured by the Evan's blue dye leakage technique (Saria & Lundberg, 1983 A time-course of the effect of CYP (150 mg kg-') was determined over a period spanning from 0.5 h to 48 h after CYP administration: the end point of the experiment was considered the start of the intracardiac perfusion procedure.
To ascertain the involvement of activation of sensory nerves in the development of plasma extravasation in this system, animals were pretreated with a single s.c. injection of capsaicin (50 mg kg-') 4 days prior to the CYP treatment and the above experiment carried out alongside vehicle (10% ethanol, 10% Tween 80 in saline) controls. The capsaicin pretreatment has been repeatedly shown to produce >90% depletion of bladder content of sensory neuropeptides (Maggi et al., 1988a,b) . From these results those time-points at which modulation by capsaicin occurred were further studied to characterize that part of the plasma extravasation response involving sensory afferent activation.
In a second series of experiments, performed 2 h after CYP administration, the effect of various drugs known to block specific receptors or prevent formation of mediators of inflammation was assessed and compared with vehicle-treated control rats carried out on the same day. The drug treatments and their relevant actions are described in Table  1 . The various in vivo treatments were selected from previous studies (referenced in 
Results
Plasma protein extravasation
The urinary bladder content of Evan's blue in control rats was 12 ± 2 ng mg-' (n = 9) of tissue.
CYP (150 mg kg-') caused a time-dependent plasma extravasation (n = 7-12 for each time-point) which reached a maximal peak at between 2 and 4 h followed by a decline over the following 24 h (Figure 1 ). Haemorrhage was apparent from the 24 h timepoint onwards. Capsaicin pretreatment (n = 7-14 for each time-point) resulted in a significant inhibition of the plasma extravasation response presented at the 2 h time-point only (P<0.01) by approximately 45% (n = 13) as shown in Figure 1 . The 2 h time-point was then used in all following in vivo experiments to characterize further the capsaicin-sensitive part of the inflammatory response to CYP. As shown in Figure 2 , RP 67,580 (0.44mgkg, n= 11), Hoe 140 (0.13mgkg', n= 16) and capsaicin pretreatment all significantly inhibited the plasma extravasation response whereas methysergide (n = 7), chlorpheniramine (n = 7), SR 48,968 (n = 7) and indomethacin (n = 7) had no significant effect. The combined administration of RP 67,580 and Hoe 140 failed to produce an inhibitory effect greater than that achieved by each antagonist alone (Figure 2 ). Table I Isolated urinary bladder strips Acrolein (1-30011M, n=7) caused a concentration-related, slowly developing, tonic contraction of rat isolated urinary bladder strips, whereas CYP (n = 9) in the same concentration range had little or no effect as shown in Figures 3a and 4. Prior incubation of the preparation with capsaicin (10 gLM) (n = 7) resulted in a suppression of the contractile effects of acrolein, significant differences being achieved at the upper part of the concentration-response curve (Figures 3a and 4) .
Administration of RP 67,580 (3 lAM) or of SR 48,968 (I ELM), at concentrations producing effective blockade of NKI and NK2 receptors respectively (Meini et al., 1993) , inhibited the response to 300 gM acrolein by 62 ± 8% and 66 ± 5% respectively (n = 5). Since muscle contraction of the rat isolated bladder to endogenous tachykinins is mediated through both NK, and NK2 receptors , the two antagonists were combined to unravel a possible contribution of endogenous tachykinins in the response to acrolein. Co-administration of the two antagonists clearly induced a more pronounced inhibition on the response to 300 ,UM acrolein (-80 ± 7%, n = 9). in the airways (Lee et al., 1992) and urinary bladder (Maggi et al., 1992) Figure 4 Typical tracings showing the concentration-dependent contractile effect of acrolein on isolated bladder from control rats (a) and from capsaicin-pretreated rats (b); (c) shows the negligible contractile effect of cyclophosphamide on isolated urinary bladder and the lack of blocking the contraction induced by capsaicin (10 gM).
part of PPE produced following CYP administration seems to be independent of an active contribution of CSPANs.
In the present series of experiments we did not demonstrate any significant potentiation of CYP induced plasma protein extravasation by capsaicin pretreatment at the 48 h time-point (Maggi et al., 1992) . A possible explanation for this anomaly may be a different source of the animals used in each study, which itself can result in significant variability in the magnitude of plasma extravasation responses even in the. same strain (Ahluwalia, unpublished observations).
With the use of the selective, non-peptide NKI receptor antagonist, RP 67,580 (Garret et al., 1991) , it would seem that at least part of the response to CYP at the 2 h timepoint is mediated through activation of these receptors by endogenous tachykinins, the most probable candidate for this being substance P. In fact, studies investigating the inflammatory effects of direct application of capsaicin to the urinary bladder have demonstrated that the ensuing PPE is due to activation of tachykinin NKI receptors (Eglezos et al., 1991) . Pretreatment with Hoe 140, the selective, potent bradykinin B2 receptor antagonist (Lembeck et al., 1991; Wirth et al., 1991) , also resulted in a significant inhibition of the oedema response. This is congruent with findings in a xylene-induced model of cystitis, where the PPE response was sensitive to both B2-receptor blockade, by Hoe 140, and NKI-receptor blockade . However, contrary to the xylene-induced cystitis, the combination of both Hoe 140 and RP 67,580, did not produce an additive inhibitory effect on CYP-induced cystitis, suggesting that the CSPAN-sensitive part of this response is dependent upon the activity of bradykinin at B2 receptors, rather than an unlinked involvement of these inflammatory mediators. In accordance with these results, it has been demonstrated, also using Hoe 140, that bradykinin is involved in the induction of detrusor hyperreflexia and increased micturition frequency during CYP-induced cystitis , events also known to be sensitive to capsaicin pretreatment.
As indicated earlier, CYP is believed to produce its toxic effects via conversion in the liver by P450 cytochrome enzymes into its active metabolite, acrolein. From the present results it would appear that CYP produces at least part of its inflammatory effects by activating CSPANs. Since it is known that capsaicin produces contractile effects upon urinary bladder through the release of tachykinins (Maggi et al., 1988c) we used this in vitro preparation to investigate whether conversion to acrolein was in fact a prerequisite for the apparent activation of CSPANs by CYP. This was achieved by comparing the contractile effects of CYP and acrolein upon the smooth muscle activity of the rat urinary bladder in vitro. The present studies demonstrate quite clearly that CYP has no direct stimulatory effects upon CSPANs, whereas acrolein produced a concentration-dependent contractile response which was attenuated to similar extents by both capsaicin pretreatment and blockade of tachykinin receptors. These antagonists had no effect upon the response curve to potassium, suggesting that the inhibitory effects of these agents on the contractile responses to acrolein do not involve a non-specific effect on bladder smooth muscle contractility.
Contrary to the in vivo experiments, in which Hoe 140 blocked CYP-induced PPE, this bradykinin B2 receptor antagonist was substantially ineffective towards acrolein on the rat isolated bladder. The latter finding could be explained by the fact that the necessary components of the kallikreinkinin system are not available for de novo bradykinin formation in vitro. Therefore, while acrolein can activate CSPANs without inducing bradykinin generation in vitro, the in vivo findings, point to bradykinin generation as a necessary intermediate step in the activation of CSPANs following CYP-induced cystitis since combination of both RP 67,580 and Hoe 140 led to no greater inhibitory effect than when either was given alone, i.e. no summation. The acroleininduced contraction of the rat isolated bladder was blocked by indomethacin, indicating that tachykinin release from CSPANs occurs via the generation of prostanoids. In contrast, indomethacin pretreatment had no effect on PPE induced by CYP administration. This second difference between the in vivo and in vitro findings may argue against the role of acrolein as activator of CSPANs during CYPinduced cystitis. At this stage we cannot clearly identify why this difference exists, however, one explanation for this anomaly could be that the amount of acrolein produced following conversion from CYP, in vivo, is much less than those concentrations used for the in vitro experiments, and that relatively low concentration of acrolein induce bradykinin generation. However, at present there exists no information concerning the ability of acrolein to induce bradykinin formation in vivo. Alternatively CYP itself or other metabolites may be capable of inducing bradykinin formation in vivo.
In conclusion, the present findings demonstrate an active role of CSPANs via tachykinin release in the early phase of the urinary bladder inflammation produced by CYP. Bradykinin generation seems an important intermediate step for CSPANs activation in in vivo conditions. Acrolein, a major metabolite of CYP, is capable of activating CSPANs in the isolated bladder; however, the mechanisms of action of acrolein in vitro appear to differ from those responsible for the in vivo inflammatory response induced by CYP.
